In this population of 131 females, we aimed to compare 49 heterozygous carriers of CYP21A2 pathogenic variants with 46 NC-CAH individuals (2 pathogenic variants identified) and 36 subjects without any pathogenic variant on CYP21A2 . The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.